Visiting Professor Lecture

All are welcome.

Lecture Title: "Management of Advanced Cutaneous Squamous Cell Carcinoma: The Patient Journey from Diagnosis to Survivorship"

Emily Ruiz, MD, MPH, is an associate physician at the Mohs and Dermatologic Surgery Center at Brigham and Women's Faulkner Hospital; associate professor in dermatology at Harvard Medical School; and program director and director of the High-Risk Skin Cancer Clinic at Dana-Farber Brigham Cancer Center.

Ruiz received her undergraduate degree from Duke University, her medical degree from New York University Grossman School of Medicine, and her master of public health degree from Harvard T.H. Chan School of Public Health. She completed an internship in internal medicine at New York University Grossman School of Medicine, a dermatology residency at Albert Einstein College of Medicine, and a fellowship in micrographic surgery and dermatologic oncology at Brigham and Women's Hospital.

Ruiz's career is dedicated to patient care, clinical innovation, education, and skin cancer research. She spends 40% of her time in outpatient clinical activities, and the remainder is devoted to clinical research and education. Most of her clinical time is spent performing Mohs micrographic surgery, and one clinic a week is at Dana-Farber Cancer Institute. This clinic is a referral site for aggressive non-melanoma skin cancers. It provides skin cancer surveillance to high-risk patients, including transplant patients and individuals with a history of high-risk skin cancer. It is also a site for two clinical trials for a programmed cell death protein 1 (PD-1) inhibitor for patients with locally advanced and metastatic cutaneous squamous cell carcinoma and basal cell carcinoma.

Ruiz's primary research interest is focused on prognostics and treatment of cutaneous squamous cell carcinoma (CSCC). She has received foundation grants to develop surveillance protocols for CSCC, assessed dermatologist-performed ultrasound, and improved prognostication of CSCC. She has National Institutes of Health (NIH) funding for a project that will incorporate artificial intelligence into CSCC prognostication.

She lives in Boston with her husband and daughters.